Maternal mortality among women with sickle cell disease in Jamaica over two decades (1998-2017)
- PMID: 34977515
- PMCID: PMC8683691
- DOI: 10.1016/j.eclinm.2021.101238
Maternal mortality among women with sickle cell disease in Jamaica over two decades (1998-2017)
Abstract
Background: Sickle cell disease (SCD) affects 2.8% of Jamaican antenatal women. Between 1998-2007 their maternal mortality ratio was 7-11 times higher than women without these disorders. We aim to determine if outcomes improved between 2008 and 17 amid declining fertility and changes in referral obstetric care.
Methods: Maternal deaths in Jamaica's maternal mortality surveillance database (assembled since 1998) with SCD reported as underlying or associated cause of death were compared to those without known SCD, over two decades from 1998 to 2017. Social, demographic and health service variables were analysed using SPSS and EpiInfo Open.
Findings: Over the two decades from 1998 to 2017, 806 (74%) of the 1082 pregnancy-associated deaths documented by the Jamaican Ministry of Health and Wellness were maternal deaths. The maternal mortality ratio (MMR) did not statistically change over the two periods for women with (p = 0.502) and without SCD (p = 0.629). The MMR among women with and without SCD in 2008-17 was 378.1 (n = 41) and 89.2/100,000 live births (n = 336) respectively, an odds ratio of 4.24 (95% CI: 3.07-5.87). When deaths due to their blood disorders were excluded, risk remained elevated at 2.17 (95% CI: 1.36-3.32). There was an upward trend in direct deaths over the two decades (p [trend]=0.051).
Interpretation: MMRs were unchanged over two decades for Jamaicans with SCD. The high contribution to maternal mortality by women with SCD may explain some of the persistently higher mortality experience of women in the African diaspora. Multi-disciplinary evidence-based strategies need to be developed and tested which improve survival for women with SCD who want to have children.
Funding: No external funding was provided.
Keywords: Direct Deaths; Jamaica; Maternal Deaths; Sickle Cell Disease; Surveillance.
© 2021 The Author(s).
Conflict of interest statement
We the authors have no conflicts of interest.
Figures



Similar articles
-
Excess risk of maternal death from sickle cell disease in Jamaica: 1998-2007.PLoS One. 2011;6(10):e26281. doi: 10.1371/journal.pone.0026281. Epub 2011 Oct 24. PLoS One. 2011. PMID: 22039456 Free PMC article.
-
The evolving contribution of non-communicable diseases to maternal mortality in Jamaica, 1998-2015: a population-based study.BJOG. 2018 Sep;125(10):1254-1261. doi: 10.1111/1471-0528.15154. Epub 2018 Jun 3. BJOG. 2018. PMID: 29419921
-
Maternal mortality at twelve teaching hospitals in Indonesia-an epidemiologic analysis.Int J Gynaecol Obstet. 1981 Aug;19(4):259-66. doi: 10.1016/0020-7292(81)90072-2. Int J Gynaecol Obstet. 1981. PMID: 6119252
-
Are maternal deaths on the ascent in Singapore? A review of maternal mortality as reflected by coronial casework from 1990 to 1999.Ann Acad Med Singap. 2002 May;31(3):261-75. Ann Acad Med Singap. 2002. PMID: 12061284
-
Maternal mortality in Jamaica.Lancet. 1986 Mar 1;1(8479):486-8. doi: 10.1016/s0140-6736(86)92939-9. Lancet. 1986. PMID: 2869218
Cited by
-
Maternal and perinatal outcomes of sickle cell disease in pregnancy: A nationwide study in France.Br J Haematol. 2025 Apr;206(4):1218-1227. doi: 10.1111/bjh.20009. Epub 2025 Feb 21. Br J Haematol. 2025. PMID: 39984807 Free PMC article.
-
Case Report: Obstetric and COVID-19-Related Morbidity and Mortality in Three Patients with Sickle Hemoglobinopathy.Am J Trop Med Hyg. 2024 Apr 23;110(6):1198-1200. doi: 10.4269/ajtmh.23-0761. Print 2024 Jun 5. Am J Trop Med Hyg. 2024. PMID: 38653217 Free PMC article.
-
Adverse pregnancy, fetal and neonatal outcomes in women with sickle cell disease in a Middle Eastern country.Womens Health (Lond). 2024 Jan-Dec;20:17455057231220188. doi: 10.1177/17455057231220188. Womens Health (Lond). 2024. PMID: 38308541 Free PMC article.
-
Prophylactic red cell transfusions for sickle cell disease pregnancy: increased use of therapy could transform outcomes.Curr Opin Hematol. 2024 Nov 1;31(6):285-293. doi: 10.1097/MOH.0000000000000837. Epub 2024 Aug 22. Curr Opin Hematol. 2024. PMID: 39177058 Review.
-
Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women.Expert Rev Hematol. 2024 Aug;17(8):493-504. doi: 10.1080/17474086.2024.2372320. Epub 2024 Jun 26. Expert Rev Hematol. 2024. PMID: 38913857 Free PMC article. Review.
References
-
- Karacaoglu P.K., Asma S., Korur A., et al. East mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients. Ann Hematol. 2016;95(6):993–1000. - PubMed
-
- Serjeant G.R., Serjeant B.E. 3rd ed. Oxford University Press; Oxford: 2001. Sickle cell disease.
LinkOut - more resources
Full Text Sources